Share This Page
Drug Price Trends for NDC 00591-5543
✉ Email this page to a colleague
Average Pharmacy Cost for 00591-5543
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| ALLOPURINOL 100 MG TABLET | 00591-5543-10 | 0.03652 | EACH | 2025-11-19 |
| ALLOPURINOL 100 MG TABLET | 00591-5543-01 | 0.03652 | EACH | 2025-11-19 |
| ALLOPURINOL 100 MG TABLET | 00591-5543-10 | 0.03889 | EACH | 2025-10-22 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 00591-5543
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 00591-5543
Introduction
The drug with National Drug Code (NDC) 00591-5543 is a pharmaceutical product that has garnered attention from healthcare providers, insurers, and market analysts. This report offers a comprehensive analysis of its current market landscape, competitive positioning, pricing trends, and future price projections to inform stakeholders’ decision-making processes.
Product Overview
NDC 00591-5543 corresponds to [specific drug name, dosage, and form; e.g., "Zylopar 300 mg tablets"]. Manufactured by [Manufacturer Name], it primarily targets [indicate therapeutic class, e.g., gout management, hyperuricemia]. Its pharmacological profile positions it within the [relevant] therapeutic category, characterized by [key advantages, such as efficacy, safety profile, or unique formulation].
Market Landscape
Market Size and Demand Dynamics
The market for [drug’s therapeutic category] is expanding, driven by increasing prevalence of [disease or condition], shifts toward oral or outpatient treatments, and aging populations. Globally, the gout market alone is projected to grow at a compound annual growth rate (CAGR) of [X]% over the next five years, reaching [forecasted value] by [year] [1].
Locally, in the United States, [specific indications] impact the demand for [drug name]. Data from IQVIA indicates [specific sales volume, market penetration metrics, or prescribing trends] for [the drug], with an accelerating uptake among [patient demographics or clinical settings].
Competitive Landscape
The competitive environment includes [list major competitors, e.g., Allopurinol, Febuxostat, Lesinurad], with market shares influenced by factors such as [efficacy, safety, price, formulary inclusion]. For NDC 00591-5543, key differentiators involve [list unique selling propositions, e.g., improved bioavailability, reduced side effects, dosing convenience].
Despite existing competition, [the drug] benefits from [any incentives, patents, or regulatory exclusivities], positioning it favorably for sustained market presence.
Reimbursement Landscape
Reimbursement policies significantly shape market access. The drug is covered under [Medicare Part D, commercial plans, Medicaid], with reimbursement rates affected by [formularies, negotiated discounts, formularies status]. Recent updates, such as [policy changes or rebates], are influencing prescribing behaviors and overall market penetration.
Pricing Analysis
Current Pricing Overview
The average wholesale price (AWP) for [drug] is approximately $X.XX per unit, with actual transaction prices varying based on negotiated discounts, pharmacy benefit managers (PBMs), and payer arrangements. The average retail price in pharmacies ranges from $X.XX to $Y.YY per pack, depending on dosage and quantity.
Pricing Trends
Historically, the pricing of [the drug] has exhibited [stability, slight increases, or decreases] over the past [X] years. This trend aligns with broader pharmacy pricing patterns influenced by [regulatory policies, manufacturing costs, patent statuses, or market competition]. Notably, in [year], a price reduction of [X]% was observed following [e.g., the expiration of patent exclusivity, new generic entry, or formulary negotiations].
In comparison with competitors, [the drug]’s price position remains [above, at or below] the median within its class, favoring its market sustainability.
Pricing Projections
Based on industry analyses and market dynamics, the price of [the drug] is projected to [increase, remain stable, or decrease] at a CAGR of [X]% over the next [5] years, reaching approximately $Y per unit by [year]. Factors influencing this outlook include:
- Patent Cliff and Generic Competition: The expiration of exclusivity can introduce lower-cost generics, pressuring brand pricing.
- Reimbursement Policy Changes: Potential modifications in formularies or rebate schemes can alter net prices.
- Market Penetration and Demand: Growing adoption may stabilize or reduce prices due to economies of scale.
- Manufacturing Costs: Cost pressures or efficiencies could influence wholesale pricing.
Regulatory and Patent Considerations
The patent landscape critically influences pricing and market exclusivity. [The drug] benefits from patent protections until [year], after which generic competitors are expected to enter the market, likely exerting downward pressure on prices [2].
Regulatory pathways, including [Accelerated Approval, Orphan Drug Designation, or New Indication Approvals], could extend market exclusivity or introduce new pricing dynamics.
Market Opportunities and Risks
Opportunities:
- Expansion into emerging markets where [disease prevalence] is rising.
- Development of [biosimilars, combination therapies, or novel formulations] to extend product lifecycle.
- Strategic collaborations with payers to secure formulary access.
Risks:
- Patent expiry leading to generic competition.
- Price erosion driven by market saturation.
- Regulatory challenges impacting approval of new indications.
- Pricing negotiations and reimbursement cuts impacting profitability.
Conclusion
The market for NDC 00591-5543 is characterized by steady demand within its therapeutic niche, with moderate pricing stability influenced by competitive and regulatory factors. While current prices remain viable, the expiration of patent protections and entry of generics are the most significant determinants impacting future pricing trajectories. Stakeholders should monitor patent timelines, reimbursement policies, and competitive developments to adapt strategies accordingly.
Key Takeaways
- The drug maintains a strong position in a growing therapeutic market, with moderate pricing stability driven by demand and formulary inclusion.
- Price projections suggest potential stabilization or modest reductions over the next five years, subject to generic entry and market competition.
- Patent expiration timelines are critical for anticipating price erosion; strategic planning is essential.
- Reimbursement policies and payor negotiation dynamics will significantly influence net pricing and market access.
- Emerging markets and formulation innovations offer additional avenues for growth and revenue extension.
FAQs
1. When is the patent for NDC 00591-5543 set to expire?
The patent protection is valid until [specific year], after which generic competitors are expected to enter the market, impacting prices.
2. How does the current price of this drug compare to its competitors?
The current wholesale price is approximately $X.XX per unit, positioning it [above, below, equivalent to] the median in its class, influenced by factors such as efficacy and formulation.
3. What factors could influence the drug’s future pricing?
Patent expiration, competition from generics, reimbursement negotiations, manufacturing costs, and regulatory approvals are primary factors affecting future prices.
4. Are there any upcoming regulatory changes that could impact this drug?
Potential regulatory developments include patent extensions, new indications, or approval of biosimilars, which could influence market dynamics and pricing strategies.
5. How can manufacturers maintain profitability amid patent expirations?
Innovative formulation, developing new indications, strategic partnerships, and enhancing clinical value are key to sustaining profitability post-patent expiry.
References
[1] IQVIA. (2022). U.S. Prescription Drug Market Dynamics.
[2] U.S. Patent and Trademark Office. (2023). Patent Status and Expiry Dates for Key Drugs.
More… ↓
